Citation Impact
Citing Papers
Characterization of a canine homolog of hepatitis C virus
2011 StandoutNobel
De novo design of allosterically switchable protein assemblies
2024 StandoutNatureNobel
Identification of a major co-receptor for primary isolates of HIV-1
1996 StandoutNature
BIRB796 Inhibits All p38 MAPK Isoforms in Vitro and in Vivo
2005
Chemokines and leukocyte traffic
1998 StandoutNature
Crystal Structure of a pol α Family Replication DNA Polymerase from Bacteriophage RB69
1997 StandoutNobel
Structure of the Replicating Complex of a Pol α Family DNA Polymerase
2001 StandoutNobel
Central nervous system injury-induced immune deficiency syndrome
2005 Standout
Early IL-6 Plasma Concentrations Correlate with Severity of Brain Injury and Pneumonia in Brain-Injured Patients
2002
Structural basis for initiation of transcription from an RNA polymerase–promoter complex
1999 StandoutNatureNobel
Molecular characterization of a peripheral receptor for cannabinoids
1993 StandoutNature
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
1998 StandoutNature
Mechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepression
1999
The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
1996 StandoutNature
The ground state of embryonic stem cell self-renewal
2008 StandoutNature
Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
2004 Standout
Crystal structure of Thermus aquaticus DNA polymerase
1995 StandoutNatureNobel
The Structure of T. aquaticus DNA Polymerase III Is Distinct from Eukaryotic Replicative DNA Polymerases
2006 StandoutNobel
Engineering Allosteric Regulation into Biological Catalysts
2009
Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors
1995
Oncogenic Mutations Counteract Intrinsic Disorder in the EGFR Kinase and Promote Receptor Dimerization
2012 StandoutNobel
Structure of Taq polymerase with DNA at the polymerase active site
1996 StandoutNatureNobel
HIV as the cause of AIDS
1996 StandoutNobel
Molecular properties of the chemokine receptor family
1994
IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-α, TGF-β1 and blood–brain barrier function
1999
CASK Functions as a Mg2+-Independent Neurexin Kinase
2008 StandoutNobel
Structure of HIV-1 RT/TIBO R 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitors
1995
The expression, localization and functional significance of β-nerve growth factor in the central nervous system
1987
HIV reverse transcriptase structure-function relationships
1991
Resistance to nevirapine of HIV-1 reverse transcriptase mutants: loss of stabilizing interactions and thermodynamic or steric barriers are induced by different single amino acid substitutions
1997
Allosteric regulation and catalysis emerge via a common route
2008
HIV Drug Resistance
1992
Two-Dimensional Crystallography of TFIIB– and IIE–RNA Polymerase II Complexes: Implications for Start Site Selection and Initiation Complex Formation
1996 StandoutNobel
The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
1996 StandoutNature
Mitogen‐activated protein kinases interacting kinases are autoinhibited by a reprogrammed activation segment
2006
Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 1. Tricyclic pyridobenzo- and dipyridodiazepinones
1991
Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 Å resolution
1992 StandoutNobel
Evaluation of antiretrovirals in animal models of HIV infection
2009
High resolution structures of HIV-1 RT from four RT–inhibitor complexes
1995
Structure of HIV-1 reverse transcriptase in a complex with the non-nucleoside inhibitor α-APA R 95845 at 2.8 å resolution
1995
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
1998 StandoutNature
Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.
1994 Standout
Binding Site Detection and Druggability Index from First Principles
2009
2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2'-dioxide)pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcriptase.
1992
Serotonin-Mediated Endocytosis of apCAM: an Early Step of Learning-Related Synaptic Growth in Aplysia
1992 StandoutScienceNobel
Chimeric human immunodeficiency virus type 1/type 2 reverse transcriptases display reversed sensitivity to nonnucleoside analog inhibitors.
1991
Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy
1994
Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
1995 StandoutScience
Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1.
1994 StandoutNobel
Crystal Structure at 3.5 Å Resolution of HIV-1 Reverse Transcriptase Complexed with an Inhibitor
1992 StandoutScience
At Least Three Human Type α Interferons: Structure of α2
1980 Science
Structural Relationship of Bacterial RecA Proteins to Recombination Proteins from Bacteriophage T4 and Yeast
1993 StandoutScienceNobel
Structural Basis of Transcription: An RNA Polymerase II Elongation Complex at 3.3 Å Resolution
2001 StandoutScienceNobel
Synaptic Activity and the Construction of Cortical Circuits
1996 StandoutScience
A family of structural genes for human lymphoblastoid (leukocyte-type) interferon
1980 Nature
Analysis of nonnucleoside drug-resistant variants of human immunodeficiency virus type 1 reverse transcriptase
1993
Redox-Controlled Selective Docking in a [2]Catenane Host
2013 StandoutNobel
Distribution of neuronal receptors for nerve growth factor in the rat
1986
Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide
2007
Novel Proteinaceous Infectious Particles Cause Scrapie
1982 StandoutScienceNobel
Aryl−Aryl Bond Formation by Transition-Metal-Catalyzed Direct Arylation
2007 Standout
Molecular basis for two different affinity states of the interleukin 2 receptor: affinity conversion model.
1986 StandoutNobel
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate
2002
Mechanism of Inhibition of HIV-1 Reverse Transcriptase by Nonnucleoside Inhibitors
1995 Science
An internal deletion in the cytoplasmic tail reverses the apical localization of human NGF receptor in transfected MDCK cells.
1991
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
1997 StandoutScienceNobel
Neurotrophins and Neuronal Plasticity
1995 StandoutScience
Human leukocyte interferon: Isolation and characterization of several molecular forms
1981
Reverse transcriptase of human immunodeficiency virus type 1: functionality of subunits of the heterodimer in DNA synthesis
1992
Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture.
1991
Viral dynamics in human immunodeficiency virus type 1 infection
1995 StandoutNature
A mutation in reverse transcriptase of bis(heteroaryl)piperazine-resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors.
1993
Expression of functional human interleukin-2 receptor in mouse T cells by cDNA transfection
1986 StandoutNatureNobel
p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.
1986
Structure of DNA Polymerase I Klenow Fragment Bound to Duplex DNA
1993 StandoutScienceNobel
DNA- and RNA-dependent DNA polymerases
1993 StandoutNobel
The Molecular Genetics of Cancer
1987 StandoutScienceNobel
Expression and structure of the human NGF receptor
1986
Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors.
1992
Characterization of two high affinity human interleukin-8 receptors.
1992
The selectivity of protein kinase inhibitors: a further update
2007 Standout
Effect of Interferon-α1 from E. coli on Some Cell Functions
1980 StandoutScienceNobel
Subunit specificity of mutations that confer resistance to nonnucleoside inhibitors in human immunodeficiency virus type 1 reverse transcriptase
1994
Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors
2004 StandoutNobel
3'-Azido-3'-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors
1992
L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase
1995
Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen.
1984
Structural Basis of Transcription: RNA Polymerase II at 2.8 Ångstrom Resolution
2001 StandoutScienceNobel
Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors
2005
Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening
2004 Standout
Functional Interactions of Neurotrophins and Neurotrophin Receptors
1995
Comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitors
1993
Activation of the Sphingomyelin Cycle Through the Low-Affinity Neurotrophin Receptor
1994 Science
Nerve growth factor increases mRNA levels for the prion protein and the beta-amyloid protein precursor in developing hamster brain.
1988 StandoutNobel
Redox Control of the Binding Modes of an Organic Receptor
2015 StandoutNobel
Characterization of the binding site for nevirapine (BI-RG-587), a nonnucleoside inhibitor of human immunodeficiency virus type-1 reverse transcriptase
1991
Interleukin-2: Inception, Impact, and Implications
1988 StandoutScience
Works of Peter M. Grob being referenced
INTRATHECAL AND SERUM INTERLEUKIN-6 AND THE ACUTE-PHASE RESPONSE IN PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURIES
1995
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
2002
Prophylaxis against HIV-1 infection in chimpanzees by nevirapine, a nonnucleoside inhibitor of reverse transcriptase
1997
Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase: Nevirapine as a Prototype Drug
1992
A novel, dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site
1991
Steady state kinetics and inhibition of HIV-1 reverse transcriptase by a non-nucleoside dipyridodiazepinone, BI-RG-587, using a heteropolymeric template
1991
Purification and Amino Terminal Sequencing of Human Melanoma Nerve Growth Factor Receptor
1987
Novel Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase. 7. 8-Arylethyldipyridodiazepinones as Potent Broad-Spectrum Inhibitors of Wild-Type and Mutant Enzymes
1998
Characterization of a receptor for human monocyte-derived neutrophil chemotactic factor/interleukin-8.
1990
Characterization of the human melanoma nerve growth factor receptor.
1985
Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies.
1984
Modification of nerve growth factor receptor properties by wheat germ agglutinin.
1983
Glycosylation of human leukocyte interferon: Effects of tunicamycin
1980
Affinity labeling and partial purification of nerve growth factor receptors from rat pheochromocytoma and human melanoma cells.
1983
Separation of human leukocyte interferon components by concanavalin A-agarose affinity chromatography and their characterization
1979